This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Nov;48(16):3123-5.

doi: 10.1016/j.ejca.2012.05.013. Epub 2012 Jun 7.

Management of bone metastases from advanced renal cell carcinoma

Muhammad Adnan Khattak, Hilary Laura Martin

PMID: 22682018
DOI: 10.1016/j.ejca.2012.05.013

Comment

Management of bone metastases from advanced renal cell carcinoma

Muhammad Adnan Khattak et al. Eur J Cancer. 2012 Nov.

. 2012 Nov;48(16):3123-5.

doi: 10.1016/j.ejca.2012.05.013. Epub 2012 Jun 7.

Authors

Muhammad Adnan Khattak, Hilary Laura Martin

PMID: 22682018
DOI: 10.1016/j.ejca.2012.05.013

No abstract available

PubMed Disclaimer

Comment on

Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma.
Keizman D, Ish-Shalom M, Pili R, Hammers H, Eisenberger MA, Sinibaldi V, Boursi B, Maimon N, Gottfried M, Hayat H, Peer A, Kovel S, Sella A, Berger R, Carducci MA. Keizman D, et al. Eur J Cancer. 2012 May;48(7):1031-7. doi: 10.1016/j.ejca.2012.02.050. Epub 2012 Mar 10. Eur J Cancer. 2012. PMID: 22409947

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information